AI assistant
Sending…
NovoCure Ltd — Director's Dealing 2018
Apr 30, 2018
31949_dirs_2018-04-30_9f5e5076-349d-4f89-a01f-8bc3e3ab84b0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Novocure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2018-04-26
Reporting Person: Ambrogi Michael J. (Chief Operating Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-04-26 | Ordinary Shares | M | 20000 | $3.44 | Acquired | 166558 | Direct |
| 2018-04-26 | Ordinary Shares | S | 13572 | $26.00 | Disposed | 152986 | Direct |
| 2018-04-26 | Ordinary Shares | S | 1800 | $26.01 | Disposed | 151186 | Direct |
| 2018-04-26 | Ordinary Shares | S | 4300 | $26.025 | Disposed | 146886 | Direct |
| 2018-04-26 | Ordinary Shares | S | 328 | $26.05 | Disposed | 146558 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-04-26 | Options to Buy Ordinary Shares | $3.44 | M | 20000 | Disposed | 2021-12-13 | Ordinary Shares (20000) | Direct |
Footnotes
F1: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi.
F2: Fully vested as of the date hereof.
More from NovoCure Ltd
Proxy Solicitation & Information Statement
2026
May 21
Regulatory Filings
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 24
Regulatory Filings
2026
Apr 9
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 26
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3